Indian Pharma News
Lupin Receives Approval from U.S. FDA for Efinaconazole Topical Solution
Lupin Limited today announced that it has received approval from the US FDA for its Abbreviated...
Read more
ALKEM enters into an exclusive license agreement with Johns Hopkins University
Johns Hopkins University, on behalf of its School of Medicine (JHU) and Alkem Laboratories Limited have...
Read more
Sequent Scientific acquires a company in Brazil
SeQuent Scientific Limited (SeQuent), having businesses in animal health sector through its principal operating company “Alivira...
Read more
ALKEM licenses technology from Harvard University
Alkem Laboratories Limited has signed a license agreement with Harvard University's Office of Technology Development (OTD)...
Read more
Amneal Enters U.S. Biosimilars Market With Approval of RELEUKO (filgrastim-ayow)
Amneal Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Biologics License...
Read more
Lupin Launches Sevelamer Hydrochloride Tablets in the United States
Lupin today announced the launch of Sevelamer Hydrochloride Tablets, 800 mg, having received an approval from...
Read more
Taro Pharma launches Taro-Cyproterone/Ethinyl Estradiol in Canada
Taro Pharmaceuticals launches Taro-Cyproterone/Ethinyl Estradiol in Canada. Taro-Cyproterone/Ethinyl Estradiol has transitioned from RAN-Cyproterone/Ethinyl Estradiol and the...
Read more
Mankind Pharma acquires Panacea Biotec’s Domestic Pharmaceutical Formulation Brands
Panacea Biotec’s Board of Directors as well as the Board of its wholly owned subsidiary viz....
Read more
Unichem receives USFDA approval for Divalproex ER Tablets
Unichem Laboratories Limited is announce that it has received ANDA approval for its Divalproex Sodium Extended-Release...
Read more
Biocon Biologics to Acquire Viatris’ Biosimilars Assets in USD 3.335 billion
Biocon Biologics Limited’s (BBL) acquisition of Viatris’ rights in biosimilars assets, creates a unique global, vertically...
Read more
Recent News
